Vancomycin-resistant Enterococcus faecium osteoarthritis following Staphylococcus aureus hip infection.
Pasticci
Maria Bruna
MB
Dept of Experimental Medicine and Biochemistry, Clinic of Infectious Diseases, Policlinico Monteluce, 06126 Perugia, Italy.
Baldelli
Franco
F
Malincarne
Lisa
L
Mancini
Giovanni Battista
GB
Marroni
Massimo
M
Morosi
Sabrina
S
Stagni
Giuliano
G
D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004338:Drug Combinations; D024881:Drug Resistance, Bacterial; D016984:Enterococcus faecium / Q000302:isolation & purification*; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D015207:Osteoarthritis, Hip / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D011475:Prosthesis Failure; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D013211:Staphylococcus aureus / Q000302:isolation & purification; D016896:Treatment Outcome; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D014640:Vancomycin